Russia says unnamed US firm violated patent rights on Sputnik V vaccine
RDIF, which actively markets Sputnik V abroad, did not disclose the name of the US firm
Empty vials of the Sputnik V (Gam-COVID-Vac) vaccine are pictured at the San Martin hospital, in La Plata, on the outskirts of Buenos Aires, Argentina January 18, 2021. REUTERS/Agustin Marcarian
Russia's RDIF sovereign wealth fund said on Monday a US firm had violated Russian patent rights on its Sputnik V vaccine against Covid-19.
RDIF, which actively markets Sputnik V abroad, did not disclose the name of the US firm.
Keep updated, follow The Business Standard's Google news channel
